secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2026-10-16T13:17:41+00:00
Accession:  0001213900-26-110051
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

OSR Health amends VXM01 license to allow $15M convertible note settlement after Nasdaq delisting
--------------------------------------------------------------------------------

- OSR Health, Vaximm AG and BCM Europe AG signed Amendment No. 1 on Oct. 15, 2026 to the April 29, 2026 global exclusive license for VXM01.
- The amendment adds Section 6.10, letting OSRH convert all or part of its unexercised $15,000,000 Equity Option into Convertible Notes that BCME or a third party buys at par.
- Notes would be issued in four $3,750,000 tranches with fixed conversion prices of about $2.00, $3.00, $4.00 and $5.00 per share, not subject to reset.
- Closing is no fewer than 20 Business Days after the Note Election Notice; failure to close within 10 Business Days after the scheduled closing withdraws the notice and reinstates the Equity Option.
- The parties cited Nasdaq Staff's Aug. 19, 2026 delisting determination and acknowledged OSR Holdings changed its name to OSR Health, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026110051/0001213900-26-110051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026110051/ea0308725-8k_osrhealth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-110051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer